Literature DB >> 28508980

An adult case of severe steroid-resistant Henoch-Schönlein purpura nephritis treated with intravenous cyclophosphamide and tonsillectomy.

Emi Sasaki1,2, Maki Shibata3, Asami Kato3, Naoto Hamano3, Takashi Katsuki3, Manami Tada3, Fumihiko Hinoshita3.   

Abstract

A previously healthy 37-year-old Canadian man living in Japan visited a hospital in Thailand while traveling because of edematous legs, purpura, arthralgia, bloody stool, and fever after an insect bite. Henoch-Schönlein purpura (HSP) was suspected. His creatinine level was 5.2 mg/dL. He was treated with oral prednisolone (PSL) and oral cyclophosphamide (CPA); after treatment, his creatinine level improved to 2.4 mg/dL. Upon returning to Japan, he was admitted to the National Center for Global Health and Medicine Hospital in Tokyo. A kidney biopsy was performed, and HSP nephritis (HSPN) was diagnosed. Renal dysfunction and proteinuria persisted despite 4 administrations of steroid-pulse therapy and 3 sessions of plasma exchange. Finally, he was treated with intravenous cyclophosphamide (IVCY). His creatinine level and proteinuria markedly improved. His microscopic hematuria disappeared after he underwent tonsillectomy. There have been only a few case reports describing patients with adult-onset HSPN necessitating IVCY. We present here a rare case of steroid-resistant HSPN treated with IVCY and tonsillectomy, with reference to some recent findings.

Entities:  

Keywords:  Cyclophosphamide (CPA); Henoch–Schönlein purpura (HSP); Intravenous cyclophosphamide therapy (IVCY); Nephrotic syndrome; Prednisolone (PSL); Tonsillectomy

Year:  2016        PMID: 28508980      PMCID: PMC5411647          DOI: 10.1007/s13730-016-0227-0

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  24 in total

1.  Addition of cyclophosphamide to steroids provides no benefit compared with steroids alone in treating adult patients with severe Henoch Schönlein Purpura.

Authors:  Evangéline Pillebout; Corinne Alberti; Loic Guillevin; Amel Ouslimani; Eric Thervet
Journal:  Kidney Int       Date:  2010-05-26       Impact factor: 10.612

2.  Apoptosis induction in human peripheral blood T lymphocytes by high-dose steroid therapy.

Authors:  K Migita; K Eguchi; Y Kawabe; T Nakamura; S Shirabe; T Tsukada; Y Ichinose; H Nakamura; S Nagataki
Journal:  Transplantation       Date:  1997-02-27       Impact factor: 4.939

3.  Seasonal distribution of Henoch-Schönlein purpura.

Authors:  S R Atkinson; D J Barker
Journal:  Br J Prev Soc Med       Date:  1976-03

4.  Successful treatment of adult-onset Henoch-Schönlein purpura nephritis with high-dose immunoglobulins.

Authors:  A Kusuda; K Migita; M Tsuboi; M Degawa; N Matsuoka; M Tominaga; A Kawakami; Y Kawabe; T Taguchi; K Eguchi
Journal:  Intern Med       Date:  1999-04       Impact factor: 1.271

5.  Henoch-Schönlein purpura in adulthood and childhood: two different expressions of the same syndrome.

Authors:  R Blanco; V M Martínez-Taboada; V Rodríguez-Valverde; M García-Fuentes; M A González-Gay
Journal:  Arthritis Rheum       Date:  1997-05

6.  Successful treatment of progressive Henoch-Schönlein purpura nephritis with tonsillectomy and steroid pulse therapy.

Authors:  Hitoshi Sugiyama; Naomi Watanabe; Tetsuya Onoda; Yoko Kikumoto; Miki Yamamoto; Manabu Maeta; Nobuya Ohara; Yohei Maeshima; Yasushi Yamasaki; Hirofumi Makino
Journal:  Intern Med       Date:  2005-06       Impact factor: 1.271

7.  [Adult case of severe Henoch-Schönlein purpura associated with steroid-resistant nephrotic syndrome successfully treated with intravenous cyclophosphamide].

Authors:  Tomoko Namba; Takeshi Yamamoto; Jun Matsuda; Hiroyuki Kadoya; Masanobu Takeji; Atsushi Yamauchi
Journal:  Nihon Jinzo Gakkai Shi       Date:  2010

8.  Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan.

Authors:  Hideo Shiiki; Takao Saito; Yoshiharu Nishitani; Tetsuya Mitarai; Noriaki Yorioka; Ashio Yoshimura; Hitoshi Yokoyama; Shinichi Nishi; Yasuhiko Tomino; Kiyoshi Kurokawa; Hideto Sakai
Journal:  Kidney Int       Date:  2004-04       Impact factor: 10.612

9.  Henoch-Schönlein purpura nephritis: course of disease and efficacy of cyclophosphamide.

Authors:  Penina Tarshish; Jay Bernstein; Chester M Edelmann
Journal:  Pediatr Nephrol       Date:  2003-11-22       Impact factor: 3.714

10.  Henoch-Schönlein Purpura in adults.

Authors:  María José López Meiller; Javier Alberto Cavallasca; María del Rosario Maliandi; Gustavo Guillermo Nasswetter
Journal:  Clinics (Sao Paulo)       Date:  2008-04       Impact factor: 2.365

View more
  2 in total

1.  Diagnosis and management of Henoch-Schonlein purpura in Indonesian elderly with severe complication: A rare case.

Authors:  Arinditia Triasti Putri
Journal:  Ann Med Surg (Lond)       Date:  2022-04-20

2.  Low-dose corticosteroid with mizoribine might be an effective therapy for elderly-onset ISKDC grade VI IgA vasculitis.

Authors:  Hikaru Sugimoto; Shiho Matsuno; Noriko Yamanaka; Wako Yumura; Mitsuyo Itabashi; Takashi Takei
Journal:  CEN Case Rep       Date:  2020-08-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.